wellrank.ai
Estraderm logo

Estraderm

First cited by AI Jun 13, 2026

Surfaced organically in AI answers about menopause and women's health. Not yet profiled.

AI Visibility

Visibility trend

Menopause and women's health, daily share of AI answers mentioning Estraderm, through Jun 13, 2026.

8.3%

Avg position when mentioned: 4.0

By engine

Where Estraderm is strong, and where it is invisible.

  • Google AI
    33.3%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 0 positive mentions
  • 1 neutral
  • 0 mixed or cautious

Recent AI answers mentioning Estraderm

Google AIJun 13, 2026, 11:05 UTC
Bioidentical hormones vs standard HRT: what is the difference?

When discussing bioidentical hormones versus standard Hormone Replacement Therapy (HRT), it's important to understand the core differences and what might be suitable for different individuals. Standard Hormone Replacement Therapy (HRT) typically refers to conventional HRT medications that are synthesized in a lab. These hormones are structurally similar to human hormones, but they may not be chemically identical. They are often derived from animal sources, such as pregnant mare's urine (for conjugated equine estrogens). Bioidentical Hormone Replacement Therapy (BHRT) uses hormones that are chemically identical to those produced by the human body. They are typically plant-derived and then chemically processed in a lab to match human hormones precisely. This means their molecular structure is exactly the same as the hormones your body naturally produces. Here's a breakdown of the key differences: Source and Structure: Standard HRT: Often uses hormones that are similar but not identical to human hormones. Some common examples include conjugated equine estrogens (like in Premarin) and synthetic progestins (like medroxyprogesterone acetate). BHRT: Uses hormones that are molecularly identical to human hormones. These are often derived from soy or yams. Examples include estradiol, estrone, and progesterone that are identical in structure to human hormones. Absorption and Metabolism: Standard HRT: Because the molecular structure might differ slightly, the body may process them differently than its own hormones. Synthetic progestins, for instance, can have different effects on the body compared to natural progesterone. BHRT: Since the hormones are identical to human hormones, they are believed to be metabolized by the body in the same way as endogenous hormones. This can potentially lead to a more natural and targeted effect. Customization: Standard HRT: Available in fixed doses and formulations. While there are various options, they are not typically compounded to individual needs. BHRT: Often available through compounding pharmacies. This allows healthcare providers to create custom formulations with specific dosages tailored to an individual's unique hormone levels and symptoms. Availability: Standard HRT: Widely available as FDA-approved prescription medications from major pharmaceutical companies. Brands like Premarin, Estrace (for estrogen), and Provera (for progesterone) are common examples. BHRT: Can be obtained through prescription from compounding pharmacies. While some bioidentical hormones are available as FDA-approved medications (e.g., Estradiol patches like Estraderm, or vaginal estrogen creams), the compounded versions are often what people refer to when discussing BHRT for systemic use. Why might someone choose one over the other? BHRT is often chosen by individuals seeking a more "natural" approach, believing that hormones identical to their own will be better tolerated and have fewer side effects. The ability to customize dosages is also a significant draw for many. Standard HRT is chosen for its established track record, wide availability, and often lower cost compared to compounded BHRT. The FDA approval for these medications means they have undergone rigorous testing for safety and efficacy. Important Considerations: Consult a Healthcare Professional: The decision between standard HRT and BHRT should always be made in consultation with a qualified healthcare provider. They can assess your individual health needs, symptoms, and risks, and recommend the most appropriate treatment plan. Evidence: While BHRT is popular, it's important to note that the scientific evidence supporting its superiority over standard HRT for all outcomes is still evolving. For many aspects of HRT, the research on FDA-approved standard HRT is more extensive. Compounding Pharmacies: If you opt for BHRT, ensure you are using a reputable compounding pharmacy that adheres to high-quality standards. In summary, the key difference lies in the molecular structure of the hormones used. BHRT uses hormones that are identical to human hormones, while standard HRT uses hormones that may be similar but not identical. Both have their pros and cons, and the best choice depends on individual needs and medical advice.

Mentioned in position 4 of 4

Read full answer with sources →

Public AI visibility history

Daily rank of Estraderm on our buyer intent questions, per category. A dash means the engines did not cite Estraderm at all that day. This record is permanent.

CategoryJun 11Jun 12Jun 13
Menopause and women's health#32

TL;DR

Estraderm is a transdermal estradiol patch developed by Novartis (originally by Ciba-Geigy) and used in hormone replacement therapy for menopausal symptoms. It delivers estradiol through the skin and is one of the earlier branded transdermal HRT products to reach the market. In WellRank's latest index it ranks twelfth in the Menopause and women's health category with 8% AI visibility, appearing in AI answers in a neutral, informational context.

Company Overview

Estraderm is a prescription pharmaceutical product rather than a standalone company; it was developed under Ciba-Geigy and later became part of the Novartis portfolio following the 1996 Ciba-Geigy and Sandoz merger. The product is marketed as a hormone replacement therapy and is sold through the conventional prescription pharmaceutical channel, with healthcare providers prescribing it and patients filling prescriptions at pharmacies. Its commercial model is that of a branded prescription drug, now facing competition from generic transdermal estradiol patches.

Product Features

  • Transdermal estradiol patch that delivers estrogen directly through the skin
  • Available in multiple dose strengths to allow individualized hormone replacement
  • Twice-weekly application schedule designed to maintain steady estradiol blood levels
  • Indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause
  • Also indicated for the prevention of postmenopausal osteoporosis in select patients

Target Market

Estraderm is prescribed primarily to women experiencing menopausal or perimenopausal symptoms, particularly hot flashes, night sweats, and related vasomotor complaints. It is also considered for women at risk of postmenopausal bone loss. The product has been available in North America and parts of Europe, though current market availability by region is not fully disclosed.

Buyer Personas

  • A perimenopausal woman in her late forties seeking non-oral estrogen delivery to manage disruptive hot flashes under her gynecologist's guidance.
  • A postmenopausal woman with osteoporosis risk factors whose physician recommends transdermal HRT as part of a bone-health management plan.
  • A patient who has experienced gastrointestinal side effects from oral estrogen and is switched by her doctor to a transdermal option.
  • A healthcare provider researching established branded transdermal estradiol options to compare against generic patches for patient counseling.

Funding & Performance

Estraderm is a prescription drug asset within Novartis, a publicly traded global pharmaceutical company (NYSE: NVS). Specific revenue figures attributable to the Estraderm brand alone are not publicly disclosed.

Recent Developments

The broader transdermal HRT market has seen significant genericization, and Estraderm faces competition from lower-cost generic estradiol patches. Novartis has over time shifted strategic focus toward other therapeutic areas, and Estraderm is generally considered a mature brand within its portfolio. No major reformulations or new indications have been widely reported in recent years.

Competitive Landscape

According to WellRank co-mention data, AI engines most frequently name Estraderm alongside Provera, Premarin, and Estrace when answering questions about menopause and women's health. Premarin and Estrace represent oral and topical estrogen alternatives, while Provera is a progestogen often discussed alongside estrogen therapy, reflecting how clinicians combine agents in HRT regimens. Generic transdermal estradiol patches also represent a significant competitive pressure given their lower cost and equivalent bioavailability profiles.

Estraderm vs the brands AI recommends alongside it

The real competitive set in Menopause and women's health: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
Estraderm logo
EstradermThis brand
#32
8.3%
Estrace logo
Estrace

1 shared answers

#8
16.7%
Premarin logo
Premarin

1 shared answers

#3
25.0%
Provera logo
Provera

1 shared answers

#10
16.7%

Email me when overtakes Estraderm

One email the day the ranks flip. Nothing else.

User Sentiment

WellRank's corpus shows Estraderm appearing in one AI-generated mention with a neutral tone and no positive or cautious framing detected, suggesting AI engines treat it as a factual reference point in HRT discussions rather than a recommended or criticized option. Public patient sentiment tends to reflect the broader conversation around HRT safety and efficacy, with transdermal delivery generally viewed favorably relative to oral estrogen for certain risk profiles. The brand does not appear to generate strong positive or negative sentiment signals in AI answer contexts at this time.

Pricing

As a prescription pharmaceutical, Estraderm pricing varies by pharmacy, insurance coverage, and geography. Exact retail or co-pay figures are not published by the manufacturer and fluctuate based on payer agreements; patients are generally directed to their pharmacy or insurer for current pricing.

Sources cited around Estraderm

The sites engines cite in answers mentioning this brand. Win these, win the answer.

    Track Estraderm weekly

    One email a week: rank moves, new competitors, and the answers that changed. No noise.

    Work at Estraderm? Get your AI Visibility Audit.

    See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.